Lechler R I, Batchelor J R
J Exp Med. 1982 Dec 1;156(6):1835-41. doi: 10.1084/jem.156.6.1835.
It has been previously shown that long surviving, enhanced (AS X AUG)F1 rat kidneys residing in a primary AS recipient are not acutely rejected if transferred into a second AS recipient. The reduced immunogenicity of the retransplanted graft was attributed to a depletion of incompatible passenger cells. It is shown here that if the primary AS recipient is made chimeric by x irradiation and injection of (AS X AUG)F1 bone marrow cells, transfer of the long surviving, enhanced graft into a second AS recipient provokes acute graft rejection comparable to that observed when normal (AS X AUG)F1 kidneys are transplanted into untreated AS recipients. Transplantation of passenger cell-depleted AUG kidneys into AS recipients leads to graft rejection, with a median survival time of 22 d. Treatment of these recipients with as little as 1.5 mg/kg cyclophosphamide for 14 d induces prolonged graft survival. By contrast, five times as much cyclophosphamide treatment is required to induce prolonged survival of normal AUG kidneys (i.e., containing incompatible passenger cells) transplanted to AS recipients. These results confirm that the major alloimmunogenic stimulus of rat kidney grafts is provided by the incompatible passenger cells.
先前的研究表明,长期存活、经过增强处理的(AS×AUG)F1大鼠肾脏,如果移植到原发性AS受体中,再将其移植到第二个AS受体中时不会被急性排斥。再次移植的移植物免疫原性降低归因于不相容过客细胞的耗竭。本文表明,如果通过X射线照射和注射(AS×AUG)F1骨髓细胞使原发性AS受体成为嵌合体,将长期存活、经过增强处理的移植物移植到第二个AS受体中会引发急性移植物排斥,这与将正常(AS×AUG)F1肾脏移植到未经处理的AS受体中时观察到的情况相当。将去除过客细胞的AUG肾脏移植到AS受体中会导致移植物排斥,中位存活时间为22天。用低至1.5mg/kg的环磷酰胺对这些受体进行14天的治疗可诱导移植物长期存活。相比之下,将正常AUG肾脏(即含有不相容过客细胞)移植到AS受体中,需要五倍剂量的环磷酰胺治疗才能诱导移植物长期存活。这些结果证实,大鼠肾脏移植物的主要同种异体免疫原性刺激是由不相容过客细胞提供的。